MODIFIED sIRNA MOLECULES AND USES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13026898

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides chemically modified siRNA molecules and methods of using such siRNA molecules to silence target gene expression. Advantageously, the modified siRNA of the present invention is less immunostimulatory than its corresponding unmodified siRNA sequence and retains full RNAi activity against the target sequence. The present invention also provides nucleic acid-lipid particles comprising a modified siRNA, a cationic lipid, and a non-cationic lipid, which can further comprise a conjugated lipid that inhibits aggregation of particles. Methods for identifying and/or modifying an siRNA having immunostimulatory properties are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROTIVA BIOTHERAPEUTICS INC100-8900 GLENLYON PARKWAY BURNABY BC V5J 5J8

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Judge, Adam Vancouver, CA 42 2288
MacLachlan, Ian Mission, CA 90 7658

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation